Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood–brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
Joana Bicker, Gilberto Alves, Ana Fortuna, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2014) Vol. 87, Iss. 3, pp. 409-432
Closed Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Therapeutic efficacy of nanoparticles and routes of administration
Dhrisya Chenthamara, Subramaniam Sadhasivam, Sankar Ganesh Ramakrishnan, et al.
Biomaterials Research (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 845
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Collin Edington, Wen Li Kelly Chen, Emily Geishecker, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 414
Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Benjamí Oller‐Salvia, Macarena Sánchez‐Navarro, Ernest Giralt, et al.
Chemical Society Reviews (2016) Vol. 45, Iss. 17, pp. 4690-4707
Open Access | Times Cited: 374
In silicoADME/T modelling for rational drug design
Yulan Wang, Jing Xing, Yuan Xu, et al.
Quarterly Reviews of Biophysics (2015) Vol. 48, Iss. 4, pp. 488-515
Open Access | Times Cited: 303
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Simon G. Patching
Molecular Neurobiology (2016) Vol. 54, Iss. 2, pp. 1046-1077
Closed Access | Times Cited: 287
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois, Loraine Campanati, Cássia Righy, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 276
Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective
Quanguo He, Jun Liu, Jing Liang, et al.
Cells (2018) Vol. 7, Iss. 4, pp. 24-24
Open Access | Times Cited: 262
In Vitro Blood–Brain Barrier Models—An Overview of Established Models and New Microfluidic Approaches
Anette S. B. Wolff, Maria Antfolk, Birger Brodin, et al.
Journal of Pharmaceutical Sciences (2015) Vol. 104, Iss. 9, pp. 2727-2746
Open Access | Times Cited: 180
Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases
Xue Zhou, Quentin R. Smith, Xinli Liu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 4
Closed Access | Times Cited: 140
Hydrogen-Bond Donors in Drug Design
Peter W. Kenny
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14261-14275
Closed Access | Times Cited: 108
Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer
L. Tiffany Lyle, Paul R. Lockman, Chris E. Adkins, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 21, pp. 5287-5299
Open Access | Times Cited: 149
Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy
Elif Ozdemir-Kaynak, Amina A. Qutub, Özlem Yeşil-Çeliktaş
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 143
Biotransformations and biological activities of hop flavonoids
Marcel Karabín, Tereza Hudcová, Lukáš Jelínek, et al.
Biotechnology Advances (2015) Vol. 33, Iss. 6, pp. 1063-1090
Closed Access | Times Cited: 127
Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
Fang Zhang, Chunlei Xu, Chunmei Liu
Drug Design Development and Therapy (2015), pp. 2089-2089
Open Access | Times Cited: 126
Blood-Brain Barrier Damage in Ischemic Stroke and Its Regulation by Endothelial Mechanotransduction
Keqing Nian, Ian C. Harding, Ira M. Herman, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 125
Adenosine receptor signaling: a key to opening the blood–brain door
Margaret S. Bynoe, Christophe Viret, Angela Yan, et al.
Fluids and Barriers of the CNS (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 123
From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier
Natascha Hartl, Friederike Adams, Olivia M. Merkel
Advanced Therapeutics (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 120
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models
Palanivel Ganesan, Hyun-Myung Ko, In‐Su Kim, et al.
International Journal of Nanomedicine (2015), pp. 6757-6757
Open Access | Times Cited: 110
Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
Yingjun Zhu, Xihong Liu, Peiyuan Zhao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 108
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels
Jérôme Robert, Emily B. Button, Brian Yuen, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 105
Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
Analiz Rodriguez, Stephen B. Tatter, Waldemar Debinski
Pharmaceutics (2015) Vol. 7, Iss. 3, pp. 175-187
Open Access | Times Cited: 98
Systemic delivery to central nervous system by engineered PLGA nanoparticles.
Qiang Cai, Long Wang, Gang Deng, et al.
PubMed (2016) Vol. 8, Iss. 2, pp. 749-64
Closed Access | Times Cited: 95
Design and Application in Delivery System of Intranasal Antidepressants
Jingying Xu, Jiangang Tao, Jidong Wang
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 93
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
Guowang Cheng, Yujing Liu, Rui Ma, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 67
The barrier and interface mechanisms of the brain barrier, and brain drug delivery
Shanshan Zhang, Lin Gan, Fengye Cao, et al.
Brain Research Bulletin (2022) Vol. 190, pp. 69-83
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top